蓝帆医疗(002382.SZ)：拟出售全资子公司武汉必凯尔全部股权

Group 1 - The core viewpoint of the article is that 蓝帆医疗 (Blue Sail Medical) plans to sell its wholly-owned subsidiary 武汉必凯尔救助用品有限公司 (Wuhan Bikaier) to focus on its core business and enhance cash reserves [1] - The transaction aims to activate existing assets and shorten management radius, indicating a strategic shift towards operational efficiency [1] - The buyer of the subsidiary is 武汉明德生物科技股份有限公司 (Wuhan Mingde Biotechnology), a company listed on the Shenzhen Stock Exchange, which is not considered a related party, thus the transaction is not classified as a major asset restructuring [1]